FISONS' OPTICROM, IMFERON MAY BE OFF U.S. MARKET UNTIL LATE 1992 AS THE COMPANY UPGRADES U.K. MANUFACTURING PLANT TO MEET FDA QUALITY CONTROL CONCERNS

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".